The Organising Committee were delighted with the attendance at the Second Ludwig Institute for Cancer Research Translational Oncology Conference held 24-26 October 2011 at the Park Hyatt Hotel Melbourne, Australia.
We would like to thank our sponsors the Ludwig Institute for Cancer Research, Pfizer, CSL, Abbott and Avipep for supporting the program.
The conference attracted international and Australian delegates and provided a unique and important forum for clinicians and scientists conducting Translational Oncology research.
This bi-annual conference seeks to promote scientific exchange and collaboration amongst scientists and clinicians involved in translational cancer research.
![]() |
Our International Guest Speakers included: Prof. Ulf Eriksson, Karolinska Institute, Sweden |
![]() |
Our National Guest Speakers included: David Bowtell, Peter MacCallum Cancer Centre, Weisan Chen, Ludwig Institute for Cancer Research, Sue Clark, Garvan Institute of Medical Research, Roger Daly, Garvan Institute of Medical Research, Mattias Ernst, Ludwig Institute for Cancer Research, Ruth Ganss, Western Australian Institute for Medical Research, Terry Johns, Monash Institute for Medical Research, Martin Lackmann, Monash University, John Mariadason, Ludwig Institute for Cancer Research, Ricky Johnstone, Peter MacCallum Cancer Centre, Michael Kershaw, Peter MacCallum Cancer Centre, Glen Marshall, Lowy Cancer Centre, Rob Ramsay, Peter MacCallum Cancer Centre, Andrew Scott, Ludwig Institute for Cancer Research, Mark Shackleton, Peter MacCallum Cancer Centre, Oliver Sieber, Ludwig Institute for Cancer Research, Mark Smyth, Peter MacCallum Cancer Centre, Steven Stacker, Peter MacCallum Cancer Centre, Andreas Strasser, The Walter and Eliza Hall Institute of Medical Research, David Vaux, The Walter and Eliza Hall Institute of Medical Research, Matthew Vardas, Centenary Institute, Jane Visvader, The Walter and Eliza Hall Institute of Medical Research, Robyn Ward, Lowy Cancer Centre |
![]() |
Conference Themes included: tumour angiogenesis and stroma, cancer immunology, signalling, |